Latest Health News

Babylon Pump & Power Limited reported a 24% revenue decline for FY2025 but achieved a 55% increase in profit, highlighting improved operational efficiency amid challenging conditions.

Cogstate Ltd has reported a strong FY25 with 22% revenue growth and a near doubling of profit before tax, declaring its first fully franked dividend and preparing to launch its inaugural AI-powered product in FY26.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

Sky New Zealand has locked in a five-year exclusive broadcast partnership with New Zealand Rugby and SANZAAR, ensuring fans access to every major rugby moment through to 2030. The deal expands coverage of both men's and women's rugby, including new tournaments and historic tours.

GLG Corp has significantly revised its profit guidance for FY2025, now expecting a net loss of up to $1.5 million, a sharp increase from earlier estimates.

MaxiPARTS Limited reported a robust FY25 with revenues climbing 9.5% to $267.1 million and net profit soaring 179% to $7.7 million, underpinned by strategic acquisitions and margin improvements.

FFI Holdings Limited reported a remarkable 283.5% jump in net profit for FY2025, driven by property revaluations and operational growth, while raising $7.2 million to fund expansion in food manufacturing and property development.

RooLife Group Ltd (ASX, RLG) has launched its proprietary RLG Coffee brand in China, tapping into a rapidly expanding market with early sales exceeding $110,000 in the first month. Strategic partnerships and a recent supply deal position RLG for broader growth in the country’s evolving consumer landscape.

Peet Limited delivered a robust FY25 performance with a 60% jump in net operating profit and a strong sales pipeline, while initiating a strategic review to capitalize on favorable market conditions.

NRW Holdings Limited has announced a fully franked ordinary dividend of AUD 0.095 per share for the six months ending June 30, 2025, signaling steady returns for shareholders.

Sonic Healthcare delivered solid FY2025 results with 8% revenue growth and a 7% rise in net profit, setting the stage for an anticipated 19% earnings per share increase in FY2026.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.